MedPath
FDA Product

Sildenafil Citrate

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Sildenafil Citrate

52817-295

Regulatory Information

52817-295

ANDA204883

C73584

June 22, 2020

USA

These highlights do not include all the information needed to use SILDENAFIL TABLETS safely and effectively. See full prescribing information for SILDENAFIL TABLETS. SILDENAFIL tablets, for oral use Initial U.S. Approval: 1998

HUMAN PRESCRIPTION DRUG LABEL

6

Company Information

TruPharma LLC

078533947

Active Ingredients

SILICA DIMETHYL SILYLATE

Code: EU2PSP0G0W

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

HYPROMELLOSES

Code: 3NXW29V3WO

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

LACTOSE MONOHYDRATE

Code: EWQ57Q8I5X

Class Code: IACT

TRIACETIN

Code: XHX3C3X673

Class Code: IACT

CROSPOVIDONE

Code: 68401960MK

Class Code: IACT

SILDENAFIL CITRATE

Quantity: 20 mg in 1 1

Code: BW9B0ZE037

Class Code: ACTIM

CELLULOSE, MICROCRYSTALLINE

Code: OP1R32D61U

Class Code: IACT

Active Moieties

SILDENAFIL

Code: 3M7OB98Y7H

© Copyright 2025. All Rights Reserved by MedPath